The Royal Adelaide Hospital, colloquially known by its initials or pronounced as "the Rah", is South Australia's largest hospital, owned by the state government as part of Australia's public health care system.

There are 800 beds in Royal Adelaide Hospital Cancer Centre.

During the past decade, Royal Adelaide Hospital Cancer Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Adelaide Hospital Cancer Centre" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "EBMT Solid Tumors Working Party" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Medical Research Council" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Adelaide Hospital Cancer Centre" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Lymphoma Trials Office" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Royal Adelaide Hospital Cancer Centre" are "Breast Cancer" (4 trials), "Lymphoma" (2 trials), "Adenocarcinoma of the Lung" (1 trials), "Approved Alternative Therapy" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Royal Adelaide Hospital Cancer Centre" in a lesser frequency.

Most popular intervention types in "Royal Adelaide Hospital Cancer Centre" are "Drug" (12 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "cyclophosphamide" (3 trials), "Carboplatin" (2 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Adelaide Hospital Cancer Centre" are 10 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Adelaide Hospital Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Royal Adelaide Hospital Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Adelaide Hospital Cancer Centre, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".